Boeck N, Trajanoski Z, Galluzzi L.
2023.
Bacterial antigens unleash tumor-targeting immunity.. Cell Host Microbe. 31(12):1945-1947.
Zhao L, Liu P, Mao M, Zhang S, Bigenwald C, Dutertre C-A, Lehmann CHK, Pan H, Paulhan N, Amon L et al..
2023.
BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance.. Cancer Discov. 13(11):2448-2469.
Choi S, Whitman MA, Shimpi AA, Sempertegui ND, Chiou AE, Druso JE, Verma A, Lux SC, Cheng Z, Paszek M et al..
2023.
Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer.. Nat Biomed Eng. 7(11):1455-1472.
Santambrogio L, Marrack P.
2023.
The broad spectrum of pathogenic autoreactivity.. Nat Rev Immunol. 23(2):69-70.
Dhaouadi N, Vitto VAngela Mar, Pinton P, Galluzzi L, Marchi S.
2023.
Ca signaling and cell death.. Cell Calcium. 113:102759.
Guilbaud E, Kroemer G, Galluzzi L.
2023.
Calreticulin exposure orchestrates innate immunosurveillance.. Cancer Cell. 41(6):1014-1016.
Galassi C, Galluzzi L.
2023.
Cancer stem cell immunoediting by IFNγ.. Cell Death Dis. 14(8):538.
Weiss TJ, Crawford ER, Posada V, Rahman H, Liu T, Murphy BM, Arnold TE, Gray S, Hu Z, Hennessey RC et al..
2023.
Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melanin.. Pigment Cell Melanoma Res. 36(1):6-18.
Agarwal PK, Sternberg CN.
2023.
Clinical Trials Corner Issue 9 (2). Bladder Cancer. 9(2):187-190.
Agarwal PK, Sternberg CN.
2023.
Clinical Trials Corner Issue 9 (4). Bladder Cancer. 9(4):377-381.
Shah SB, Carlson CR, Lai K, Zhong Z, Marsico G, Lee KM, Vélez NEFélix, Abeles EB, Allam M, Hu T et al..
2023.
Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas.. Nat Mater. 22(4):511-523.
Popic V, Rohlicek C, Cunial F, Hajirasouliha I, Meleshko D, Garimella K, Maheshwari A.
2023.
Cue: a deep-learning framework for structural variant discovery and genotyping.. Nat Methods. 20(4):559-568.
Liu W, Newhall KP, Khani F, Barlow LM, Nguyen D, Gu L, Eng K, Bhinder B, Uppal M, Récapet C et al..
2023.
The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.. Cancer Res. 83(4):506-520.